title: High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia.
authors.affiliation: Department of Medicine, University Hospital Rebro, Zagreb, Yugoslavia.
authors.forename: D
authors.initials: D
authors.lastname: Nemet
authors.forename: B
authors.initials: B
authors.lastname: Labar
authors.forename: V
authors.initials: V
authors.lastname: Bogdanić
authors.forename: E
authors.initials: E
authors.lastname: Hauptman
authors.forename: B
authors.initials: B
authors.lastname: Jaksić
authors.forename: H
authors.initials: H
authors.lastname: Minigo
authors.forename: D
authors.initials: D
authors.lastname: Sertić
authors.forename: M
authors.initials: M
authors.lastname: Mrsić
authors.forename: Z
authors.initials: Z
authors.lastname: Pavletić
authors.forename: J
authors.initials: J
authors.lastname: Kovacević
mesh_terms: D000328:Adult; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D003561:Cytarabine